Bisphosphonate use for osteoporosis in postmenopausal women may inhibit occurrence of malignant microcalcification in breast tissue.
Altundag
Kadri
K
Silay
Yavuz S
YS
Altundag
Ozden
O
Atik
Mustafa A
MA
Aktolga
Serdal
S
D050071:Bone Density Conservation Agents / Q000494:pharmacology; D001940:Breast / Q000378:metabolism / Q000473:pathology*; D001941:Breast Diseases / Q000209:etiology*; D002114:Calcinosis / Q000209:etiology*; D002118:Calcium / Q000378:metabolism; D002128:Calcium Metabolism Disorders; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D017698:Postmenopause
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D002118:Calcium